methyl 2-tetradecylglycidate has been researched along with tolbutamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, W; Kirsch, T; Mohrbacher, RJ; Tutwiler, GF | 1 |
| Elks, ML | 1 |
2 other study(ies) available for methyl 2-tetradecylglycidate and tolbutamide
| Article | Year |
|---|---|
Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)--an orally effective hypoglycemic agent.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Fats; Dogs; Dose-Response Relationship, Drug; Epoxy Compounds; Ethers, Cyclic; Fasting; Fatty Acids; Female; Glucose Tolerance Test; Hypoglycemic Agents; Ketone Bodies; Ketosis; Male; Mice; Oxidation-Reduction; Pancreas; Propionates; Rats; Tolbutamide | 1978 |
Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release.
Topics: Animals; Arginine; Epoxy Compounds; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Perfusion; Propionates; Rats; Rats, Wistar; Stearic Acids; Tolbutamide | 1993 |